Article
A Genetic Variant rs10251977 in Long Non-coding RNA EGFR-AS1 Creates a New Binding Site for miR-891b and Modulates the Expression of EGFR A/D Isoforms
2020-12-31
Abstract excerpt
Tyrosine kinase inhibitor (TKI) is one of the effective chemo-preventive approaches against tumors that deregulate EGFR pathway. About 80% of HNSCC patients overexpress EGFR, making TKI an effective treatment against this cancer. Recently a synonymous variant rs10251977 in exon 20 of EGFR reported to act as a prognostic marker in HNSCC. Analysis of this germline variant in blood samples of oral cancer patients sho...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 7a94270a-a330-5e3c-b422-bfa7f0c882b4
- DOI
- 10.21203/rs.3.rs-136285/v1
